CARBOPROST TROMETHAMINE

N/A

Manufactured by Pharmacia & Upjohn Company LLC

2,057 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CARBOPROST TROMETHAMINE

CARBOPROST TROMETHAMINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Pharmacia & Upjohn Company LLC. The most commonly reported adverse reactions for CARBOPROST TROMETHAMINE include VOMITING, NAUSEA, OFF LABEL USE, DIARRHOEA, ABDOMINAL PAIN UPPER. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CARBOPROST TROMETHAMINE.

Top Adverse Reactions

VOMITING207 reports
NAUSEA187 reports
OFF LABEL USE139 reports
DIARRHOEA132 reports
ABDOMINAL PAIN UPPER94 reports
CHEST DISCOMFORT88 reports
ABDOMINAL DISCOMFORT67 reports
DYSPNOEA64 reports
ABDOMINAL PAIN61 reports
BLOOD PRESSURE INCREASED59 reports
PALPITATIONS40 reports
DIZZINESS37 reports
HYPERHIDROSIS37 reports
GASTROINTESTINAL DISORDER36 reports
HEADACHE35 reports
PRURITUS31 reports
DISCOMFORT29 reports
HEART RATE INCREASED29 reports
OXYGEN SATURATION DECREASED29 reports
FLUSHING24 reports
RASH24 reports
TACHYPNOEA23 reports
ASTHENIA21 reports
COUGH20 reports
DRUG INEFFECTIVE20 reports
HYPERTENSION20 reports
PRODUCT USE ISSUE20 reports
PYREXIA20 reports
RASH ERYTHEMATOUS20 reports
CHILLS18 reports
ANAL INCONTINENCE16 reports
ERYTHEMA15 reports
BLOOD PRESSURE DECREASED13 reports
DRUG HYPERSENSITIVITY12 reports
TACHYCARDIA12 reports
BRONCHOSPASM11 reports
ABDOMINAL DISTENSION10 reports
EXPOSURE DURING PREGNANCY10 reports
HYPOAESTHESIA10 reports
INJECTION SITE ERYTHEMA10 reports
PRODUCT USE IN UNAPPROVED INDICATION10 reports
COLD SWEAT9 reports
DYSPHORIA9 reports
PALLOR9 reports
URTICARIA9 reports
HYPERSENSITIVITY8 reports
MATERNAL EXPOSURE DURING PREGNANCY8 reports
PRODUCTIVE COUGH8 reports
TREMOR8 reports
BODY TEMPERATURE INCREASED7 reports
RETCHING7 reports
SEIZURE7 reports
SUFFOCATION FEELING7 reports
TEMPERATURE INTOLERANCE7 reports
CHEST PAIN6 reports
DYSPEPSIA6 reports
FEELING COLD6 reports
HYPOTENSION6 reports
INCORRECT ROUTE OF DRUG ADMINISTRATION6 reports
INJECTION SITE RASH6 reports
ANAPHYLACTIC SHOCK5 reports
CARDIAC ARREST5 reports
CYANOSIS5 reports
HAEMORRHAGE5 reports
INJECTION SITE PAIN5 reports
INJECTION SITE SWELLING5 reports
MUSCLE SPASMS5 reports
OROPHARYNGEAL DISCOMFORT5 reports
RESPIRATORY RATE INCREASED5 reports
ACUTE RESPIRATORY FAILURE4 reports
AGITATION4 reports
BLOOD POTASSIUM DECREASED4 reports
CONFUSIONAL STATE4 reports
ECLAMPSIA4 reports
FAECES DISCOLOURED4 reports
FATIGUE4 reports
FEELING HOT4 reports
GASTROINTESTINAL PAIN4 reports
GASTROOESOPHAGEAL REFLUX DISEASE4 reports
HEART RATE DECREASED4 reports
INCREASED BRONCHIAL SECRETION4 reports
MUSCLE TWITCHING4 reports
PAIN4 reports
POSTPARTUM HAEMORRHAGE4 reports
SENSATION OF FOREIGN BODY4 reports
SUPERFICIAL VEIN THROMBOSIS4 reports
SWELLING4 reports
VISION BLURRED4 reports
WHEEZING4 reports
ACUTE PULMONARY OEDEMA3 reports
ANAPHYLACTIC REACTION3 reports
ARRHYTHMIA3 reports
BLOOD PRESSURE SYSTOLIC INCREASED3 reports
CIRCULATORY COLLAPSE3 reports
FEEDING DISORDER3 reports
HYPOAESTHESIA ORAL3 reports
INJECTION SITE BRUISING3 reports
LARYNGOSPASM3 reports
LIP SWELLING3 reports
MENTAL STATUS CHANGES3 reports

Report Outcomes

Out of 682 classified reports for CARBOPROST TROMETHAMINE:

Serious 95.7%Non-Serious 4.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female664 (99.3%)
Male4 (0.6%)
Unknown1 (0.1%)

Reports by Age

Age 3257 reports
Age 2855 reports
Age 3042 reports
Age 2737 reports
Age 3337 reports
Age 2635 reports
Age 2935 reports
Age 3135 reports
Age 2534 reports
Age 3434 reports
Age 3632 reports
Age 2428 reports
Age 3728 reports
Age 3525 reports
Age 3816 reports
Age 2215 reports
Age 2311 reports
Age 4110 reports
Age 219 reports
Age 399 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CARBOPROST TROMETHAMINE?

This profile reflects 2,057 FDA FAERS reports that mention CARBOPROST TROMETHAMINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CARBOPROST TROMETHAMINE?

Frequently reported terms in FAERS include VOMITING, NAUSEA, OFF LABEL USE, DIARRHOEA, ABDOMINAL PAIN UPPER, CHEST DISCOMFORT. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CARBOPROST TROMETHAMINE?

Labeling and FAERS entries often list Pharmacia & Upjohn Company LLC in connection with CARBOPROST TROMETHAMINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.